Activity
3K followers
-
Huan Le shared thisObservations on ChatGPT3: https://lnkd.in/g-wwyUWt
-
Huan Le shared thisThought my next car would be an EV but 2nd thoughts after reading this hysterical article: https://lnkd.in/gHAxaNWtI Rented an Electric Car for a Four-Day Road Trip. I Spent More Time Charging It Than I Did Sleeping.I Rented an Electric Car for a Four-Day Road Trip. I Spent More Time Charging It Than I Did Sleeping.
-
Huan Le shared thisIf anyone knows a good litigator who's looking for a new opportunity: https://lnkd.in/gaphRUMG
-
Huan Le shared thisCheck out Brainome's Auto ML benchmarking to see how we compare against Amazon, Google & Microsoft. #AutoML #Benchmark #bigdata #artificialintelligence #machinelearning #openml
-
Huan Le shared thisBetter than any start up story you've ever read: Halting Progress and Happy Accidents: How mRNA Vaccines Were Made https://nyti.ms/3fuht0SHalting Progress and Happy Accidents: How mRNA Vaccines Were Made (Published 2022)Halting Progress and Happy Accidents: How mRNA Vaccines Were Made (Published 2022)
-
Huan Le shared thisFor everyone who loved the "The Wire": The Question Michael K. Williams Asked Before Every Season of ‘The Wire’ https://nyti.ms/3hpW75QOpinion | The Question Michael K. Williams Asked Me Before Every Season of ‘The Wire’ (Published 2021)Opinion | The Question Michael K. Williams Asked Me Before Every Season of ‘The Wire’ (Published 2021)
-
Huan Le shared thisA great article on how the Pfizer vaccine was "programmed" https://lnkd.in/givCgeEReverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine - Bert Hubert's writingsReverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine - Bert Hubert's writings
Huan Le replied to a comment
8mo
Hadar Weiss The line comes from the movie business where nobody knows why certain movies resonant with audiences and others don't.
-
Huan Le liked thisHuan Le liked this🎉 We're excited to share that Cellular Vehicles has been awarded an NIH Phase II SBIR — $2M to scale automated cell-laden hydrogel manufacturing on our Odyssey System, continuing our work with Christopher Rodell at Drexel University. The problem: localized cell therapy delivery only works when cells stay where you delivered them — embedding them in shear-thinning hydrogels enables this. Preparing cells-in-gel by hand is inconsistent, tough to cryopreserve, and difficult to scale. Our Phase I work proved the Odyssey System could close and automate the workflow. Phase II is about taking it from proof-of-concept to a clinic-ready platform. What's next: ⚙️ Harden the cells-in-gel automation workflow toward GMP-readiness 📼 Develop an easy-to-use disposable kit 💉 Validate injectability through clinically-relevant models 🏥 Pilot with therapy developers This is a real step toward standardizing a next-gen drug delivery strategy. We're grateful to our other Drexel collaborators (Kara Spiller, Ph.D., Alexander Osidach) for pushing this forward with us. Reach out to learn more! The National Institutes of Health National Center for Advancing Translational Sciences (NCATS) #CellTherapy #SBIR #Automation #Hydrogels #RegenerativeMedicine
-
Huan Le liked thisHuan Le liked thisMy cofounder and I were thinking about quitting. Then a customer asked for a call. I figured: this is it, churn. Startups are hard. If you don't think about quitting, you have never been a founder. Bootstrapping is 100x harder because there is no salary or resources. Not a below-market salary. Not a token salary. No. Salary. At. All. No budgets unless you get revenue. You're just running a normal business. Which is also hard. So every time a customer asks to meet, I worry. Are they happy? Will they churn? I always start in the darkest place. We depend on that revenue. For everything. This one was different. She was thrilled. Two weeks in, she'd already closed two customers. The first thing she said was "how can I help you get more customers?" Then: "I want to refer everyone." After a brutal month in startupland, I needed that call. Thank you.
-
Huan Le liked thisHuan Le liked thisIntroducing Hands-On 👋🏽✨ A new series highlighting the founders, funders, and operators rolling up their sleeves and building what’s next. For our first feature, we’re spotlighting Su Sanni, founder of Dollaride. Sanni is reimagining transportation access by building solutions that make mobility more affordable and accessible for communities that have historically been overlooked. Read to learn more about what Su Sanni is building, his thoughts on scaling in the climate sector, and what most people are overlooking in the space: https://lnkd.in/emMKxiSM
-
Huan Le liked thisHuan Le liked thisBehind every deal is a reason someone showed up. 🤝 Our co-founder and CEO Su Sanni grew up in East New York, walking over a mile to the nearest subway. His uncles — Nigerian immigrants — were among the early pioneers of the city's dollar van industry, building something from the ground up to move the neighbors around them. That legacy is why Dollaride exists. "We trust where we're headed, and we know that we can get there together." — Su Sanni, Dollaride For Yeng Felipe Butler, founding partner and CEO of Chestnut Run Capital Partners, it was personal before it was a deal: "When I heard what Dollaride was doing, I knew personally the gap that needed to be filled." — Yeng Felipe Butler, Chestnut Run Capital Partners And for Jon Stafford, CMA, CAFM at Zeti, it's about pointing hard-won expertise at a problem that can actually be solved: "There are so many problems in the world that I don't know how to solve. But this is one that seems like there's really tangible answers." — Jon Stafford, Zeti That's the through-line: small fleet owners keep this city moving, and clean transportation should be within reach for the entrepreneurs who've earned it. The financing is the mechanism. The mission is the point. 🚐 ⚡ Read more here: https://lnkd.in/gTHMX3gp #CleanTransportation #FleetElectrification #NEMT #EVs #ClimateFinance #NewYork #MissionDriven #UrbanTransit
-
Huan Le liked thisHuan Le liked thisSmall fleet owners keep this city moving. But when they're ready to go electric, capital is rarely ready for them. Lenders see small fleets as risky — not because they are, but because they can't see inside them. 🎥👇 That's the problem this partnership was built to solve. In this conversation, our co-founder and CEO Su Sanni sits down with Zeti and Chestnut Run Capital Partners to break down how we financed electric vehicles now serving non-emergency medical transportation (NEMT) routes in New York — and what it means for every fleet owner who's been told "not yet" by traditional financing: ⚡ Dollaride operates and deploys the EVs, backed by a track record of execution 📊 Zeti's platform gives all three partners one shared, real-time view of the fleet — utilization, asset values, CO₂ savings, community impact — right alongside the financials 🤝 Chestnut Run brings capital that looks for "impact above and beyond the financials" When lenders can see how assets are actually performing, perceived risk stops standing between small fleet owners and the capital they've earned. As our partners put it in the video: that transparency is "game-changing for the industry." And this is a blueprint, not a one-off — multiple projects and multiple deals ahead, so more owners can electrify their fleets and keep serving the communities that depend on them. Read the full story behind the partnership: https://lnkd.in/giunadF3 #CleanTransportation #FleetElectrification #NEMT #EVs #ClimateFinance #NewYorkCityDollaride, Zeti & Chestnut Run — Electrifying NYC's Transportation LegacyDollaride, Zeti & Chestnut Run — Electrifying NYC's Transportation Legacy
-
Huan Le liked thisHuan Le liked thisBig news! 🎉 Dollaride just took home the Fleet Optimization Pioneers award from Autofleet! 🏆 We’re making fleet electrification effortless for community transit operators with our new EV-as-a-Service model. By combining vehicles, routing, charging, financing, and parking into one unified offering, we’re paving a practical pathway to EV adoption while driving down costs and emissions. 🚐⚡🌍 Read all about how we won at the 2026 Optimizers Awards here: 👉 https://lnkd.in/gicmd6fP #EV #CleanTech #FleetManagement #Sustainability #Dollaride #AutofleetHow Dollaride Won the Fleet Optimization Pioneers Award at The 2026 Optimizers AwardsHow Dollaride Won the Fleet Optimization Pioneers Award at The 2026 Optimizers Awards
-
Huan Le liked thisI had a fun chat on the current state of advanced molecular diagnostic companies, including innovation, commercialization and fundraising.Huan Le liked thisStart with Reimbursement and Work Backwards - Jonathan Romanowsky In this episode of Diagnosing Dx, I’m joined by Jonathan Romanowsky, co-founder of Inflammatix, Inc. Jonathan shares lessons from leading diagnostics launches at CareDx, Inc., CardioDx, Veracyte, Inc., and Inflammatix. We discuss commercialization, reimbursement, fundraising, and why startups need to think about market adoption much earlier than before. 🔥 Key takeaways: 🔹 Why reimbursement strategy needs to shape diagnostics planning from the start 🔹 What makes a launch succeed beyond strong science and clinical validation 🔹 Why early-stage companies now need commercial credibility much sooner 🔹 How Inflammatix evolved from a molecular signature company into an IVD platform business 🔹 What diagnostics founders need to understand about scale, systems, and adoption in 2026 🎧 Listen/watch now on: 🔹 YouTube: https://lnkd.in/eKxDueqs 🔹 Spotify: https://lnkd.in/erJygqHh 🔹 Apple: https://apple.co/4vPhW2z
-
Huan Le liked thisWe won again! LingoQuesto was selected as one of the winners of the third and final START Fellowship Investment Committee session, receiving an additional CHF 30,000 (~$38k USD) in equity-free funding to keep accelerating our vision. Thank you to the START Global team and jury for believing in what we’re building!Huan Le liked thisOn Monday, we had the last Investment Committee session of the program! The jury had a difficult task to deliberate between the eight start ups chosen to pitch: Blinka, Menta, Ghyperion, Runni, Lothgha, LiLi App, Astrocor and LingoQuesto. Congratulations to the four winners: - Menta (Michelle Benenzon) - Runni (Juan José Melguizo Ramírez) - LingoQuesto (Tomas Vallejo Zangen Vallejo) - Astrocor (Ivan Díaz Arenas) And thank you to QoQa for hosting us in their beautiful Bussigny offices and to the jury for their support: Patrick Hertzog, Juliane Butty, Charlie Graham-Brown, CFA and Sebastián Mejía Camacho !!
-
Huan Le liked thisHuan Le liked thisWe just built something with Claude that shouldn't be possible. 16 hours a day. Over a year now. I’ve been trying to make Julian Gay's and my startup dream a reality. Ups, downs (even losing our biggest customer just 2 months after acquiring them) None of it really worked until we switched the way we worked. 2 weeks ago. We ignored our outreach platform. And put everything in Claude. Allowing customers to set up, review, and send email campaigns. Without ever leaving Claude. No opening a saas tool. No gmail. No leaving the platform. Just… “Hey Claude, pull all my new accounts with the signal for executives talking about AI and prepare an email campaign for me to review” Review. Send. It’s so cool. So with that I want to formally say. Skyp is launching in Claude!! And it’s out now. The goal isn’t to allow someone to blast 100,000 emails out. It’s to do hyper-targeted outreach. Using signals powered by BirdDog. Without ever leaving Claude. I’m so excited for this new chapter. Still just myself and Julian. But this is the future. End to end outreach in Claude.
Experience & Education
Languages
-
Vietnamese
Limited working proficiency
-
English
Native or bilingual proficiency
Other similar profiles
Explore more posts
-
Arjun Malhotra
Orange Health Labs has always been committed to six-hour reporting. Not "as fast as possible" but specifically six hours, no exceptions. This one constraint made them build everything differently. They couldn't use standard labs designed for average daily volume - they had to build for peak hourly capacity. They couldn't have doctors at each location, so they built remote pathology, where one doctor reviews slides from multiple cities. They couldn't rely on traditional logistics - so they created dedicated networks covering four times the area of competitors. Now incumbents can't copy it without scrapping their existing infrastructure. They have hundreds of labs built the old way, doctors hired locally, and established logistics. Retrofitting would cost more than starting from scratch, and starting from scratch means abandoning their existing business. I like how Orange Health's edge is that matching their model means incumbents must treat their current infrastructure as sunk cost. This is the kind of advantage that compounds.
3 Comments -
Nadav Shimoni, M.D.
Some quick and candid / not just bullish observations on AI in digital health, especially given the enormous level of noise at #JPM2026. Last (5th) post in the 5-on-5 series, opening 2026 with 5 different pieces with 5 observations each on the market for digital health founders. We are passed the hype phase. I actually think 2026 will be the year when saying 'AI' or 'Agentic' will raise more questions than applause. Too many pilots are not scaling, too many promises are yet to be fulfilled. When building a product takes less time, the path to commoditization also takes less time. Scribes, chart summarizations, etc. which leads IMO to NRR being much more important than ARR (show you are resilient to price pressure and churn) Most real impact of AI is on the back end of new companies. This is massive and hence any budget that looks similar to 2023 / 2024 or even 2025 budgets should render a very serious question As a byproduct, and unlike 2021, increased head count becomes a negative signal if the company is indeed AI-centered (proxy to inefficiency) And another key difference from 2021: raising a lot of money (with a big valuation) while the public market is at best open for high 9-digit revenue, is really playing very aggressive poker. For additional color, see this interview with CTech by Calcalist (first comment)
6 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content